PTX 2.27% 4.5¢ prescient therapeutics limited

Ann: PTX CellPryme-M presentation, page-12

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 40 Posts.
    lightbulb Created with Sketch. 256
    Agree, the latest Cell Therapy Enhancement data reads very well.

    Regarding leak theory though, you could be right but the share price has been on a steady rise since the announcement of 4th complete response and cohort expansion in AML. Note this piece alone could turn PTX into a multi multi bagger. Might be an accumulation just based on that.

    Cheers
    CB

 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.